A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

Clinical trial NCT06588738 · COMPLETED

Trial details

NCT number: NCT06588738
Sponsor: Alumis Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2024-08-20
Primary completion: 2025-09-23
Enrollment: 862

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.